& Monument Traders Alliance
Good day, 360!
Here are some of our top movers today. Please join us TODAY for the Daily Cash Code. ONE Stock. ONE Trade. Every Day. LIVE FRIDAY MAY 30TH @ 10AM ET.
Be the best prepared trader on the Street!
FOCUS LIST🔎
BLRX – Up over 130% in the pre-market after announcing positive data in Pancreatic Cancer (PDAC) trial
TIRX – Up over 32% in pre after announcing acquisition of Ucare Inc. in US$150 million all-stock deal, advancing in-hospital health insurance strategy
PATH – Up over 13% in pre after reporting better than expected earnings
*Together with Monument Traders Alliance
Access Nate Bear’s #1 Pick of the MONTH and track it with him LIVE every week
(& 365 day FULL refunds)
Next Pick of the MONTH drops on MONDAY
HOTLIST🔥
BLRX – Up over 130% in the pre-market after announcing positive data in Pancreatic Cancer (PDAC) trial
BioLineRx Ltd. (BLRX) is a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare disease.
In the pre-market this morning, the company announcedthat a poster including new data from the single-arm pilot phase of the investigator-initiated, randomized CheMo4METPANC Phase 2 combination clinical trial will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30-June 3, 2025 in Chicago, Illinois.
Highlights include:
– 4 of 11 PDAC patients in the pilot phase remained progression free at over one year
– Poster presentation on Saturday, May 31st
Shares of BLRX traded up over 130% in the pre-market in reaction to the news.
The $5.60 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $6.50, $7, $8, $9 and then the pre-market high at $10.01.
Below it, targets to the downside are $5, $4.50, $4.20 and then a gap fill at $3.79.
TIRX – Up over 32% in pre after announcing acquisition of Ucare Inc. in US$150 million all-stock deal, advancing in-hospital health insurance strategy
TIAN RUIXIANG Holdings Ltd (TIRX) is a China-based insurance broker.
In the pre-market this morning, the company announcedplans to acquire 100% of issued and outstanding shares of Ucare Inc., the sole operator of China’s only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million.
This strategic move aims to unlock new growth opportunities in the health insurance segment.
Under the Agreement, the Sellers will receive 101,486,575 newly-issued class A ordinary shares of TRX, each with a par value of US$0.025. The number of Shares is calculated based on the weighted average closing price of TRX’s Class A ordinary shares over the three months preceding the Agreement, at a per-share price of US$1.478. The Shares will represent approximately 91.75% of the Company’s total issued and outstanding Class A ordinary shares and approximately 13.70% of its total voting power upon closing, which is subject to customary conditions.
Shares of TIRX traded up over 32% in the pre-market in reaction to the news.
The $2.30 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $2.50, $2.80, $3.26, $3.38.
Below $2.30, targets to the downside are $2.12 and then a gap fill at 1.83 with $1.60 below that.
*sponsored by 1440 Media
Receive Honest News Today
Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.
PATH – Up over 13% in pre after reporting better than expected earnings
UiPath, Inc. (PATH) is a global leader in agentic automation,
In the after-hours yesterday, the company reportedfinancial results for its first quarter fiscal 2026 ended April 30, 2025.
Highlights include:
Revenue of $357 million increases 6 percent year-over-year
ARR of $1.693 billion increases 12 percent year-over-year
Cash flow from operations reaches $119 million and non-GAAP adjusted free cash flow reaches $117 million
Shares of PATH traded up over 13% in the pre-market in reaction to the news.
The $14.10 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $14.75, and then the after hours high at $15.05. Beyond that, $15.35 and $16 come into play.
Below $14.10, targets to the downside are $13.70, $13.40 and then a gap fill at $12.94.
MARKET NEWS 📰
Don’t miss out on our MOBILE ALERTS! Some of these alerts have rocketed 🚀past the MOON 🌝. Text “RAGE” to 1-(888) 487-1534📲.
*Disclosure: By texting “RAGE” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content:If you purchase anything through a link in this email other than RagingBull (RB) services, you should assume that we have an affiliate relationship with the company providing the product that you purchase, and that we will be paid in some way. RB is not responsible for any content hosted on affiliate’s sites and it is the affiliate’s responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don’t spend any money on these products unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
